Memantine-induced speech problems in two patients with autistic disorder

DARU, Journal of Pharmaceutical Sciences

Volumn 21, Issue 1, 2013, Pages

  Alaghband Rad, Javad ^a   Nikvarz, Naemeh ^b   Tehrani Doost, Mehdi ^a   Ghaeli, Padideh ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Autism spectrum disorder; Memantine; Stuttering

Indexed keywords

MEMANTINE; RISPERIDONE;

ARTICLE; AUTISM; BREATHING; CASE REPORT; CHILD; CHILD PSYCHIATRY; CHILDHOOD DISEASE; DETERIORATION; DISEASE EXACERBATION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; HUMAN; MALE; PRESCHOOL CHILD; SCHOOL CHILD; SPEECH; STUTTERING;

EID: 84880289542     PISSN: 15608115     EISSN: 20082231     Source Type: Journal    
DOI: 10.1186/2008-2231-21-54     Document Type: Article

References (28)

1. Epidemiology of stuttering: 21st century advances. Yairi E, Ambrose N, J Fluency Disord 2013 38 66 87 10.1016/j.jfludis.2012.11.002 23773662
2. Overview of the diagnosis and treatment of stuttering. Maguire GA, Yeh CY, Ito BS, J ExpClin Med 2012 4 92 97
3. Stuttering as a side-effect of divalproex sodium. Aukst-Margetic B, Margetic B, Psychiatry Clin Neurosci 2008 62 748 19068016
4. Stutter exacerbated by lithium in a pediatric patient with bipolar disorder. Gulack BC, Puri NV, Kim WJ, Ann Pharmacother 2011 45 57 10.1345/aph.1Q140 21917558
5. A case of bupropion-induced stuttering. Fetterolf F, Marceau M, Gen Hospital Psychiatry 2012 http://dx.doi.org/10.1016/j.genhosppsych.2012.07.003
6. Clozapine-induced stuttering: a case report and analysis of similar case reports in the literature. Grover S, Verma AK, Nebhinani N, Gen Hospital Psychiatry 2012 34 703.e1 703.e3 10.1016/j.genhosppsych.2012.02.010
7. Olanzapine- and clozapine-induced stuttering. a case series. Bar KJ, Hager F, Sauer H, Pharmacopsychiatry 2004 37 131 134 15179972 (Pubitemid 38680335)
8. Reversible language regression as an adverse effect of topiramate treatment in children. Gross-Tsur V, Shalev RS, Neurology 2004 62 299 300 10.1212/01.WNL.0000103285.85821.B3 14745074 (Pubitemid 38167145)
9. Drug-induced stuttering: a review of the literature. Brady JP, J Clin Psychopharmacol 1998 18 50 54 10.1097/00004714-199802000-00008 9472842 (Pubitemid 28045634)
10. Stuttering, The effect of treatment with D-amphetamine and a tranquilizing agent, trifluoperazine: a preliminary report on an uncontrolled study. Fish CH, Bowling E, Calif Med 1965 103 337 339 5836893
11. Risperidone induced stuttering. Yadav DS, General Hospital Psychiatry 2010 32 559.e9 559.e10 10.1016/j.genhosppsych.2010.01.004
12. Stuttering and stimulants. Burd L, Kerbeshian J, J Clin Psychopharmacol 1991 11 72 10.1097/00004714-199102000-00020 2040720
13. Further defining the language impairment of autism: is there a specific language impairment subtype? Whitehouse AJO, Barry JG, Bishop DVM, J CommDisord 2008 41 319 333
14. Differential language markers of pathology in autism, pervasive developmental disorder Not otherwise specified and specific language impairment. Demouy J, Plaza M, Xavier J, Ringeval F, Chetouani M, Perisse D, Chauvin D, Viaux S, Golse B, Cohen D, Robel L, Res Autism Spectrum Disord 2011 5 1402 1412 10.1016/j.rasd.2011.01.026
15. Brief report: relations between prosody performance and communication and socialization ratings in high functioning speakers with autism spectrum disorders. Paul R, Shriberg LD, McSweeny J, Cicchetti D, Klin A, Volkmar F, J Autism DevDisord 2005 35 861 869 10.1007/s10803-005-0031-8
16. Speech and prosody characteristics of adolescents and adults with high- functioning autism and asperger syndrome. Shriberg LD, Paul R, McSweeny JL, Klin A, Cohen DJ, Volkmar FR, J Speech Lang Hear Res 2001 44 1097 1115 10.1044/1092-4388(2001/087) 11708530 (Pubitemid 34014169)
17. Memantine: a treatment for Alzheimer's disease with a new formulation. Makino KM, Porsteinsson AP, Aging Health 2011 7 342 369
18. Memantine as adjunctive therapy in chidren diagnosed with autistic Spectrum Disorders: an observation of initial clinical response and maintenance tolerability. Chez MG, Burton Q, Dowling T, Chang M, Khanna P, Kramer C, J Child Neurol 2007 22 574 579 10.1177/0883073807302611 17690064 (Pubitemid 46951501)
19. A prospective, open-label trial of memantine in the treatment of cognitive, behavioral, and memory dysfunction in Pervasive Developmental Disorders. Owley T, Salt J, Guter S, Grieve A, Walton L, Ayuyao N, Leventhal BL, Cook EH, J Child Adolesc Psychopharmacol 2006 16 517 524 10.1089/cap.2006.16. 517 17069541 (Pubitemid 44737207)
20. Glutamate antagonists seem to be slightlyeffective in psychopharmacologic treatment of autism. Niederhofer H, J Clin Psychopharmacol 2007 27 317 10.1097/01.jcp.0000270082.30500.69 17502791 (Pubitemid 46763326)
21. A retrospective study of memantine in children and adolescents with pervasive developmental disorders. Erickson CA, Posey DJ, Stigler KA, Mullett J, Katschke AR, McDougle CJ, Psychopharmacology 2007 191 141 147 10.1007/s00213-006-0518-9 17016714 (Pubitemid 46294942)
22. Frontal lobe nonconvulsive status epilepticus: a case of epileptic stuttering, aphemia, and aphasia-not a sign of psychogenic nonepileptic seizures. Kaplan PW, Stagg R, Epilepsy Behav 2011 21 191 195 10.1016/j.yebeh.2011.03.028 21543261
23. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Johnson BA, Ait-Daoud N, Bowden CL, DiClemente CC, Roache JD, Lawson K, Javors MA, Ma JZ, Lancet 2003 361 1677 1685 10.1016/S0140-6736(03) 13370-3 12767733 (Pubitemid 36577440)
24. Memantine side effects, [ http://www.drugs.com/sfx/memantine-side- effects.html ]
25. Memantine and constraint-induced aphasia therapy in chronic poststroke aphasia. Berthier ML, Green C, Lara JP, Higueras C, Barbancho MA, Dávila G, Pulvermuller F, Ann Neurol 2009 65 577 585 10.1002/ana.21597 19475666
26. Stuttering: an update for physicians. Costa D, Kroll R, CMAJ 2000 162 1849 1855 10906923 (Pubitemid 30463159)
27. Olanzapine in the treatment of developmental stuttering: a double-blind, placebo-controlled trial. Maguire GA, Riley GD, Franklin DL, Maguire ME, Nguyen CT, Brojeni PH, Ann Clin Psychiatry 2004 16 63 67 10.1080/10401230490452834 15328899 (Pubitemid 39070971)
28. Management of child and adolescent stuttering with olanzapine: three case reports. Lavid N, Franklin DL, Maguire GA, Ann Clin Psychiatry 1999 4 233 236